Evidence explainer

Prevention, nutrition, and travel health

Questions to Bring to a Diabetes Appointment

A useful diabetes visit connects your glucose patterns with safety, heart and kidney risk, and what matters to you. One page of notes buys back most of the time.

Fully reviewed by Jasaman (Jasmin) Tojjar, MD, PhD

On this page
  1. Prepare a one-page snapshot
  2. “What are my glucose goals, and why?”
  3. “Am I having hypoglycemia, including episodes I do not notice?”
  4. “Does my treatment still fit my heart, kidney, and weight risks?”
  5. “Which complication checks are due?”
  6. “Could another condition or treatment be changing my diabetes?”
  7. “How should I use my devices and data?”
  8. “What can I do between visits, and when should I call?”
  9. A closing check that prevents confusion

The best diabetes appointment is not a test of whether you have been “good.” It is a joint review of what is working, what feels unsafe or burdensome, and what should change next. Glucose is important, but comprehensive care also includes cardiovascular and kidney risk, medication effects, and complications. It includes emotional health, nutrition, physical activity, and sleep. It includes access and your own goals.

Prepare a one-page snapshot#

An appointment often begins with reconstruction. Which medicines are you actually taking? At what dose and time? What changed since the last visit? A concise snapshot preserves the time for decisions.

Include all prescription medicines, over-the-counter products, and supplements. Include insulin type and dose, injection timing, and how you take them in real life. Note missed or delayed doses and the reason: cost, schedule, or side effects. The reason can also be uncertainty, fear of hypoglycemia, or something else. Bring the containers or your pharmacy list if names are unclear.

For home glucose checks, bring your meter or a log that includes times and context, and for continuous glucose monitoring, a shared report can show time in range and time below range. It can also show variability and daily patterns. Add events that data cannot explain: illness, steroids, travel, or fasting. Shift work, exercise, and menstrual changes belong there. So do alcohol and a sensor problem.

Write down the two or three issues that matter most to you. A new symptom, recurrent low glucose, or medicine cost should not be crowded out by a routine checklist. Neither should pregnancy planning, driving safety, or difficulty obtaining supplies.

“What are my glucose goals, and why?”#

An A1C target is not universal. The 2026 American Diabetes Association standards emphasize individualization based on overall health, diabetes duration and complications, and life expectancy. Individualization also rests on cognitive and functional status, treatment burden, resources, and risk of hypoglycemia. Ask which A1C, fasting, after-meal, or continuous-monitor goals apply to you and what benefit your team expects from reaching them.

Also ask whether A1C is accurately reflecting glucose. Conditions affecting red-cell turnover, hemoglobin variants, recent blood loss or transfusion, pregnancy, and advanced kidney disease can make interpretation difficult; a mismatch between your A1C and your meter or sensor readings deserves investigation rather than automatic treatment escalation.

Useful questions include:

The aim is a target that supports your health without unacceptable low glucose or burden.

“Am I having hypoglycemia, including episodes I do not notice?”#

Low glucose can cause sweating, shaking, and hunger. It can cause confusion, behavior change, or seizures. It can cause loss of consciousness, injury, and cardiac stress. Recurrent episodes may blunt warning symptoms. If you use insulin, sulfonylureas, or meglitinides, review frequency and timing. Review severity, possible causes, and whether another person had to help.

Ask what value counts as low for the action plan, how to treat it, when to recheck, and when emergency help is needed. Confirm access to unexpired glucagon and whether the people you live with know how to use it when severe hypoglycemia is possible. Discuss driving and work at heights or around machinery. Discuss exercise, alcohol, and overnight risk.

Sensor alarms are useful but require an agreed response. Compression lows, lag during rapid change, and occasional device error can all occur, so ask when a finger-stick confirmation is appropriate. Do not silence recurrent alarms without understanding the pattern.

“Does my treatment still fit my heart, kidney, and weight risks?”#

For many people with type 2 diabetes, medicine choice is not driven by A1C alone. Atherosclerotic cardiovascular disease, heart failure, chronic kidney disease, and obesity may change which therapy offers the best balance. So may hypoglycemia risk, adverse effects, route, and cost.

Ask whether your kidney function changes the dose or safety of the medicines you already take, and ask whether a medicine with demonstrated cardiovascular or kidney benefit is appropriate given your conditions, even if glucose is near target. That does not mean every newer drug is suitable. Contraindications, side effects, and interactions matter. So do access, pregnancy considerations, and individual goals.

If weight change is a priority, define a safe and realistic goal and how nutrition, activity, medicines, sleep, and other conditions contribute; unintentional weight loss is different from planned weight management and should be reported.

Questions worth asking are:

Never stop insulin or another prescribed medicine solely on the basis of a general online “sick-day” rule. The plan depends on the drug and clinical situation.

“Which complication checks are due?”#

Diabetes complications can be silent. The timing of screening depends on diabetes type, duration, and previous findings. It also depends on pregnancy and other risks. Ask for a schedule built around you rather than assuming every test is annual for everyone.

Kidney assessment commonly uses estimated glomerular filtration rate and a urine albumin-to-creatinine ratio. These measure different aspects of kidney health; one normal result does not substitute for the other. Temporary illness, exercise, or fever can affect urine albumin, and so can marked hyperglycemia or menstruation. An unexpected result may therefore require confirmation.

Eye screening looks for retinopathy before vision changes become obvious. Ask whether the next examination needs dilation and whether retinal photography or an eye specialist is appropriate. Report new floaters, a curtain-like shadow, sudden visual loss, or marked vision change promptly.

Foot review should cover skin, deformity, pulses, and sensation. It should cover footwear, previous ulcers, and self-care. A warm swollen foot, spreading redness, or black tissue needs urgent assessment. So does a deep wound or systemic illness. People with reduced sensation may not feel an injury.

Also ask about blood pressure, lipids, and dental care. Ask about hearing when relevant, liver risk, and sleep apnea. Ask about sexual or bladder symptoms, neuropathic pain, and vaccines. Screening should lead to an action plan, not merely a completed box.

“Could another condition or treatment be changing my diabetes?”#

Steroid medicines, acute infection, or endocrine disorders can alter glucose or self-management. So can pregnancy, menopause, or sleep disruption. So can depression, disordered eating, pain, and changes in mobility. Diabetes itself can coexist with autoimmune disease, fatty liver disease, and heart failure. It can coexist with kidney disease and other conditions that change treatment choices.

Bring new diagnoses and medicines from every clinician. Ask who is coordinating changes when several specialists are involved. A prescription that is appropriate for one condition may affect glucose or kidney function. It may affect appetite, hydration, or hypoglycemia risk.

Mental health belongs in the visit. Diabetes distress, depression, anxiety, and fear of low glucose can make a technically elegant regimen unworkable. So can cognitive change, substance use, and burnout. Asking for diabetes education, behavioral health support, or nutrition care is part of treatment. So is asking for a pharmacist review or social-work help.

“How should I use my devices and data?”#

A meter, sensor, or pump should answer a defined question. So should a connected pen or an app. Ask which reports the team reviews, how data are shared, what alarm settings mean, and what to do when a device fails, and confirm backup insulin delivery and glucose-testing plans for pump or sensor interruptions.

For continuous glucose monitoring, ask how time in range and time below range apply to you. A good average can conceal dangerous lows or wide swings. Conversely, a few isolated readings may not justify changing a regimen without context.

Technology should reduce burden or improve safety. If adhesives cause skin problems or alarms disrupt your sleep, say so. Say so if data sharing feels intrusive or supplies are unaffordable. Those tradeoffs belong in shared decision-making.

“What can I do between visits, and when should I call?”#

Leave with specific next steps. Who adjusts insulin and by what rule? Which readings or symptoms trigger a message? How are lab results communicated? What is the plan for travel, fasting, procedures, or illness? When is follow-up, and which tests should occur beforehand?

Ask for urgent-care thresholds tailored to you. Severe hypoglycemia, altered consciousness, or trouble breathing requires prompt emergency assessment. So do signs of stroke or heart attack, persistent vomiting with inability to keep fluids down, or possible diabetic ketoacidosis. Ketone testing and sick-day instructions are especially important for people at risk of insulin deficiency or taking medicines associated with ketoacidosis.

A closing check that prevents confusion#

Before leaving, restate the plan in plain language: “I will change this dose on this date, check these readings, complete these tests, and contact this person if this happens.” This teach-back step catches misunderstandings without blaming the patient.

Obtain an updated medication list and written instructions. If several changes are proposed, ask which is most important and how success or harm will be judged, and a manageable plan followed safely is more useful than a long plan nobody can implement.

Sources and further reading

  1. American Diabetes Association, Comprehensive Medical Evaluation and Assessment of Comorbidities, Standards of Care in Diabetes, 2026
  2. American Diabetes Association, Glycemic Goals and Hypoglycemia, Standards of Care in Diabetes, 2026
  3. American Diabetes Association, Pharmacologic Approaches to Glycemic Treatment, Standards of Care in Diabetes, 2026
  4. American Diabetes Association, Cardiovascular Disease and Risk Management, Standards of Care in Diabetes, 2026
  5. American Diabetes Association, Chronic Kidney Disease and Risk Management, Standards of Care in Diabetes, 2026
  6. Centers for Disease Control and Prevention, Your Diabetes Care Schedule

Questions and answers

Do I need to bring every glucose reading?

Bring the device or an organized report when possible. Patterns with dates, times, meals, activity, symptoms, and medicine timing are more informative than selected “good” or “bad” readings.

What if I did not follow the plan?

Say what happened and why. Missed doses, food insecurity, side effects, cost, depression, schedule changes, and fear of low glucose are information the care team needs to make treatment safer and more realistic.

Is A1C the only number that matters?

No. Time spent with low glucose, glucose variability, blood pressure, lipids, kidney measures, symptoms, quality of life, and treatment burden may all change the decision.

How often should diabetes appointments occur?

It depends on stability, treatment changes, complications, pregnancy, hypoglycemia, and access. The care team should state the follow-up interval and what should prompt an earlier review.

Should a family member come?

If the person wants support, a trusted care partner can help with history, instructions, devices, and severe-hypoglycemia planning. The patient should remain central to the conversation and decide what may be shared.